Gradient Investments’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-47,990
| Closed | -$13M | – | 355 |
|
|
2025
Q3 | $13M | Buy |
+47,990
| New | +$13.1M | 0.22% | 133 |
|
|
2024
Q3 | – | Sell |
-70,880
| Closed | -$13.9M | – | 481 |
|
|
2024
Q2 | $13.9M | Sell |
70,880
-1,133
| -2% | -$234K | 0.31% | 112 |
|
|
2024
Q1 | $15.5M | Buy |
72,013
+1,585
| +2% | +$333K | 0.36% | 106 |
|
|
2023
Q4 | $14.8M | Sell |
70,428
-16,443
| -19% | -$3.51M | 0.36% | 107 |
|
|
2023
Q3 | $17.4M | Sell |
86,871
-2,381
| -3% | -$473K | 0.46% | 60 |
|
|
2023
Q2 | $16.5M | Buy |
89,252
+1,322
| +2% | +$244K | 0.43% | 79 |
|
|
2023
Q1 | $16.8M | Buy |
87,930
+4,569
| +5% | +$826K | 0.46% | 61 |
|
|
2022
Q4 | $14M | Buy |
83,361
+83,177
| +45,205% | +$14.5M | 0.44% | 79 |
|
|
2022
Q3 | $33K | Sell |
184
-53
| -22% | -$10.5K | ﹤0.01% | 557 |
|
|
2022
Q2 | $48K | Sell |
237
-7
| -3% | -$1.48K | ﹤0.01% | 482 |
|
|
2022
Q1 | $58K | Sell |
244
-134
| -35% | -$31.5K | ﹤0.01% | 447 |
|
|
2021
Q4 | $86K | Sell |
378
-58,662
| -99% | -$12.9M | ﹤0.01% | 384 |
|
|
2021
Q3 | $11.4M | Buy |
59,040
+3,535
| +6% | +$716K | 0.32% | 97 |
|
|
2021
Q2 | $11.8M | Buy |
55,505
+1,588
| +3% | +$335K | 0.35% | 77 |
|
|
2021
Q1 | $11M | Buy |
53,917
+3,579
| +7% | +$705K | 0.36% | 72 |
|
|
2020
Q4 | $8.42M | Sell |
50,338
-720
| -1% | -$122K | 0.36% | 83 |
|
|
2020
Q3 | $8.54M | Buy |
51,058
+4,531
| +10% | +$763K | 0.36% | 83 |
|
|
2020
Q2 | $7.56M | Buy |
46,527
+396
| +0.9% | +$71K | 0.34% | 84 |
|
|
2020
Q1 | $7.98M | Buy |
46,131
+194
| +0.4% | +$38.6K | 0.43% | 65 |
|
|
2019
Q4 | $9.22M | Buy |
45,937
+1,754
| +4% | +$360K | 0.41% | 81 |
|
|
2019
Q3 | $9.34M | Sell |
44,183
-4,264
| -9% | -$891K | 0.46% | 59 |
|
|
2019
Q2 | $9.4M | Buy |
48,447
+6,626
| +16% | +$1.22M | 0.48% | 52 |
|
|
2019
Q1 | $6.88M | Buy |
41,821
+41,768
| +78,808% | +$7.38M | 0.45% | 70 |
|
|
2018
Q4 | $10K | Sell |
53
-76
| -59% | -$14K | ﹤0.01% | 575 |
|
|
2018
Q3 | $22K | Sell |
129
-79
| -38% | -$13.3K | ﹤0.01% | 477 |
|
|
2018
Q2 | $34K | Buy |
208
+53
| +34% | +$8.66K | ﹤0.01% | 389 |
|
|
2018
Q1 | $25K | Buy |
+155
| New | +$24.7K | ﹤0.01% | 438 |
|
|
2015
Q4 | – | Sell |
-1
| Closed | – | – | 681 |
|
|
2015
Q3 | $0 | Buy |
+1
| New | +$95 | ﹤0.01% | 608 |
|
|
2013
Q4 | – | Sell |
-45
| Closed | -$3K | – | 585 |
|
|
2013
Q3 | $3K | Buy |
+45
| New | +$3.31K | ﹤0.01% | 376 |
|
Other funds holding CME
Gradient Investments's CME Position: Q4 2025 in Review
Gradient Investments sold out of CME Group (CME) in Q4 2025, closing a stake of 47,990 shares — an estimated $13M sold.
Gradient Investments first reported a position in CME in Q3 2013 and held it in 29 quarters. The position peaked at $17.4M in Q3 2023. 1,736 funds tracked by Wall St. Rank hold CME as of Q4 2025.
- Gradient Investments reported no remaining CME Group position as of Q4 2025 after selling out during the quarter.
- Gradient Investments sold 47,990 CME Group shares in Q4 2025, an estimated $13M.
- Gradient Investments first reported a position in CME Group in Q3 2013 and held it in 29 quarters.
- Gradient Investments's CME Group position peaked at $17.4M in Q3 2023.
- 1,736 funds tracked by Wall St. Rank held CME Group as of Q4 2025.
Based on Gradient Investments's 13F filing for Q4 2025, filed 8 Jan 2026.